Description
GDC-0349isanATP-competitiveinhibitorofmTORthatexhibitsanticancerchemotherpeuticactivity.GDC-0349displayspre-clinicalefficacyinvitroandinvivo.
GDC-0349isanATP-competitiveinhibitorofmTORthatexhibitsanticancerchemotherpeuticactivity.GDC-0349displayspre-clinicalefficacyinvitroandinvivo.
| CasNo. | 1207360-89-1 |
|---|---|
| Purity | ≥98% |
| Formula | C24H32N6O3 |
| FormulaWt. | 452.55 |
| IUPACName | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
| Synonym | GDC0349 |
| Appearance | Tantoyellowsolid |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | G1310InfoSheetPDF |
|---|---|
| Brochures | PI3K-Akt-mTORCPathwayBooklet |
PeiZ,BlackwoodE,LiuL,etal.DiscoveryandBiologicalProfilingofPotentandSelectivemTORInhibitorGDC-0349.ACSMedChemLett.2012Nov29;4(1):103-7.PMID:24900569.